This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michailowsky, V.
Right arrow Articles by Gazzinelli, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michailowsky, V.
Right arrow Articles by Gazzinelli, R. T.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 1998, p. 2549-2556, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Interleukin-12 Enhances In Vivo Parasiticidal Effect of Benznidazole during Acute Experimental Infection with a Naturally Drug-Resistant Strain of Trypanosoma cruzi

Vladimir Michailowsky,1,2 Silvane M. F. Murta,1,3 Leonardo Carvalho-Oliveira,2 Maria E. S. Pereira,2 Ludmila R. P. Ferreira,1,2 Zigman Brener,2 Alvaro J. Romanha,3 and Ricardo T. Gazzinelli1,2,*

Department of Biochemistry and Immunology, Federal University of Minas Gerais, 30270-010 Belo Horizonte, MG,1 and Laboratory of Chagas' Disease,2 and Laboratory of Cellular and Molecular Parasitology,3 Centro de Pesquisas René Rachou, Oswaldo Cruz Foundation, 30190-002 Belo Horizonte, MG, Brazil

Received 30 December 1997/Returned for modification 27 April 1998/Accepted 16 July 1998

The roles of gamma interferon (IFN-gamma ) and interleukin-12 (IL-12) in mediating and/or enhancing the in vivo trypanosomicidal activity of the nitroheterocyclic derivative benznidazole (Bz) were evaluated during early stages of experimental Chagas' disease. Our results show that treatment of Trypanosoma cruzi-infected mice with anti-cytokine monoclonal antibodies (MAbs) had no apparent effect when the optimal dose of Bz (100 mg/kg of body weight) was used. In contrast, treatment with anti-IL-12 or anti-IFN-gamma MAbs enhanced the parasitemia and accelerated the mortality of mice treated with a suboptimal dose of Bz (25 mg/kg). Simultaneous treatment with a suboptimal dose of Bz and recombinant IL-12 (rIL-12) enhanced the efficacy of drug treatment in terms of parasitemia and mouse survival. Interestingly, we found that drug-resistant T. cruzi strains were found to be poor inducers of IL-12 both in vitro and in vivo compared to strains of T. cruzi which are susceptible or partially resistant to Bz treatment. These results suggest that early activation of the cellular compartment of the immune system by IL-12 may favor in vivo Bz activity against T. cruzi. In order to test this hypothesis mice infected with the drug-resistant Colombiana strain of T. cruzi were treated with 100 mg of Bz per kg plus different concentrations of rIL-12. By using the results of PCR and serological and parasitological methods as the criteria of a cure, our results indicate that a higher percentage of mice treated with Bz combined with rIL-12 than mice treated with Bz alone are cured.

* Corresponding author. Mailing address: Laboratory of Chagas' Disease, Centro de Pesquisas René Rachou, FIOCRUZ, Av. Augusto de Lima 1715, 30190-002 Belo Horizonte, MG, Brazil. Phone: 55-31-295-3566. Fax: 55-31-295-3115. E-mail: ritoga{at}mono.icb.ufmg.br.

Antimicrobial Agents and Chemotherapy, October 1998, p. 2549-2556, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Ferraz, M. L., Gazzinelli, R. T., Alves, R. O., Urbina, J. A., Romanha, A. J. (2009). Absence of CD4+ T Lymphocytes, CD8+ T Lymphocytes, or B Lymphocytes Has Different Effects on the Efficacy of Posaconazole and Benznidazole in Treatment of Experimental Acute Trypanosoma cruzi Infection. Antimicrob. Agents Chemother. 53: 174-179 [Abstract] [Full Text]  
  • Martins, H. R., Figueiredo, L. M., Valamiel-Silva, J. C. O., Carneiro, C. M., Machado-Coelho, G. L. L., Vitelli-Avelar, D. M., Bahia, M. T., Martins-Filho, O. A., Macedo, A. M., Lana, M. (2008). Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes. J Antimicrob Chemother 61: 1319-1327 [Abstract] [Full Text]  
  • Hyland, K. V., Leon, J. S., Daniels, M. D., Giafis, N., Woods, L. M., Bahk, T. J., Wang, K., Engman, D. M. (2007). Modulation of Autoimmunity by Treatment of an Infectious Disease. Infect. Immun. 75: 3641-3650 [Abstract] [Full Text]  
  • Ferraz, M. L., Gazzinelli, R. T., Alves, R. O., Urbina, J. A., Romanha, A. J. (2007). The Anti-Trypanosoma cruzi Activity of Posaconazole in a Murine Model of Acute Chagas' Disease Is Less Dependent on Gamma Interferon than That of Benznidazole. Antimicrob. Agents Chemother. 51: 1359-1364 [Abstract] [Full Text]  
  • Gomes, J. A. S., Bahia-Oliveira, L. M. G., Rocha, M. O. C., Busek, S. C. U., Teixeira, M. M., Silva, J. S., Correa-Oliveira, R. (2005). Type 1 Chemokine Receptor Expression in Chagas' Disease Correlates with Morbidity in Cardiac Patients. Infect. Immun. 73: 7960-7966 [Abstract] [Full Text]  
  • Villarreal, D., Nirde, P., Hide, M., Barnabe, C., Tibayrenc, M. (2005). Differential Gene Expression in Benznidazole-Resistant Trypanosoma cruzi Parasites. Antimicrob. Agents Chemother. 49: 2701-2709 [Abstract] [Full Text]  
  • Gomes, J. A. S., Bahia-Oliveira, L. M. G., Rocha, M. O. C., Martins-Filho, O. A., Gazzinelli, G., Correa-Oliveira, R. (2003). Evidence that Development of Severe Cardiomyopathy in Human Chagas' Disease Is Due to a Th1-Specific Immune Response. Infect. Immun. 71: 1185-1193 [Abstract] [Full Text]  
  • Miyahira, Y., Katae, M., Takeda, K., Yagita, H., Okumura, K., Kobayashi, S., Takeuchi, T., Kamiyama, T., Fukuchi, Y., Aoki, T. (2003). Activation of Natural Killer T Cells by {alpha}-Galactosylceramide Impairs DNA Vaccine-Induced Protective Immunity against Trypanosoma cruzi. Infect. Immun. 71: 1234-1241 [Abstract] [Full Text]  
  • Olivieri, B. P., Cotta-de-Almeida, V., Araujo-Jorge, T. (2002). Benznidazole Treatment following Acute Trypanosoma cruzi Infection Triggers CD8+ T-Cell Expansion and Promotes Resistance to Reinfection. Antimicrob. Agents Chemother. 46: 3790-3796 [Abstract] [Full Text]  
  • Saraiva, V. B., Gibaldi, D., Previato, J. O., Mendonca-Previato, L., Bozza, M. T., Freire-de-Lima, C. G., Heise, N. (2002). Proinflammatory and Cytotoxic Effects of Hexadecylphosphocholine (Miltefosine) against Drug-Resistant Strains of Trypanosoma cruzi. Antimicrob. Agents Chemother. 46: 3472-3477 [Abstract] [Full Text]  
  • Michailowsky, V., Silva, N. M., Rocha, C. D., Vieira, L. Q., Lannes-Vieira, J., Gazzinelli, R. T. (2001). Pivotal Role of Interleukin-12 and Interferon-{gamma} Axis in Controlling Tissue Parasitism and Inflammation in the Heart and Central Nervous System during Trypanosoma cruzi Infection. Am. J. Pathol. 159: 1723-1733 [Abstract] [Full Text]  
  • Molina, J., Martins-Filho, O., Brener, Z., Romanha, A. J., Loebenberg, D., Urbina, J. A. (2000). Activities of the Triazole Derivative SCH 56592 (Posaconazole) against Drug-Resistant Strains of the Protozoan Parasite Trypanosoma (Schizotrypanum) cruzi in Immunocompetent and Immunosuppressed Murine Hosts. Antimicrob. Agents Chemother. 44: 150-155 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»